<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0032019" disease_type="Neoplastic Process" abbrv="">Pituitary tumor</z:e>-transforming gene (PTTG), the index mammalian securin, is abundantly expressed in several <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and regulates <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and progression </plain></SENT>
<SENT sid="1" pm="."><plain>Molecular mechanisms elucidating PTTG regulation and actions remain elusive </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we provide evidence that PTTG acts as a signal transducer and activator of transcription factor 3 (STAT3) target gene </plain></SENT>
<SENT sid="3" pm="."><plain>Total STAT3 and Tyr705 phosphorylated STAT3 were concordantly expressed with PTTG in human <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> (n=97 and n=95, respectively, P&lt;0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>STAT3 specifically bound the human PTTG promoter and induced PTTG transcriptional activity (twofold) as assessed by chromatin immunoprecipitation and luciferase reporter assays </plain></SENT>
<SENT sid="5" pm="."><plain>STAT3 transfection increased PTTG <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein abundance twofold in HCT116 human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells, and induction was further enhanced (threefold) by constitutively active STAT3 (STAT3-C), whereas strongly abrogated by dominant-negative STAT3 (STAT3-DN) </plain></SENT>
<SENT sid="6" pm="."><plain>Attenuating PTTG expression by siRNA in STAT3 HCT116 stable transfectants suppressed cell growth and colony formation in vitro, and PTTG cell knockout also constrained activated STAT3-induced explanted murine <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in vivo </plain></SENT>
<SENT sid="7" pm="."><plain>STAT3 increased HCT116 cell migration and invasion up to fivefold, whereas cell mobility was abolished by STAT3-DN (&gt;85%) </plain></SENT>
<SENT sid="8" pm="."><plain>Impairing PTTG expression by siRNA also strongly suppressed STAT3-faciliated cell migration and invasion by up to 90% </plain></SENT>
<SENT sid="9" pm="."><plain>Knocking out PTTG in STAT3-C HCT116 stable transfectants strongly decreased <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice, indicating the requirement of PTTG for STAT3-promoted <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>These results elucidate a mechanism for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell PTTG regulation, whereby STAT3 induces PTTG expression to facilitate <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and further support the rationale for targeting PTTG to abrogate <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> growth.Oncogene advance online publication, 18 February 2013; doi:10.1038/onc.2013.16 </plain></SENT>
</text></document>